Reprogrammed tumour cells to be used as therapeutic cancer vaccine for treating cancer
Stanford School of Medicine - 01-Mar-2023T cells are trained to recognize cancer antigens, which attack the cancer cells when reintroduced into the body
Join the club for FREE to access the whole archive and other member benefits.
Communications manager, Institute for Stem Cell Biology and Regenerative Medicine
Christopher Vaughan is the communications manager for the Stanford Institute for Stem Cell Biology and Regenerative Medicine. Email him at vaughan1@stanford.edu.
Visit website: http://christovaughan.com/
See also: Stanford University School of Medicine - Medical school that improves health through discoveries and innovation in health care, education and research
Details last updated 20-Aug-2020
T cells are trained to recognize cancer antigens, which attack the cancer cells when reintroduced into the body
Treating with BMP2 and Csf1 antagonist in mice restored youthfulness to the aged skeletal system
Principle tested and a success in mice and humans, to ease arthritis in the future